In vivo Ryr2 editing corrects catecholaminergic polymorphic ventricular tachycardia
收藏NIAID Data Ecosystem2026-03-10 收录
下载链接：
https://www.ncbi.nlm.nih.gov/bioproject/PRJNA483082
下载链接
链接失效反馈官方服务：
资源简介：
Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a lethal inherited arrhythmia disorder most commonly caused by missense mutations in the RyR2 gene. The goal of this study was to determine whether somatic in vivo gene editing using the CRISPR/Cas9 system delivered by adeno-associated viral (AAV) vectors could correct CPVT arrhythmias in mice heterozygous for RyR2 mutation R176Q (R176Q/+).
创建时间：
2018-07-26
